Prelude Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Prelude Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,400	Closed	-$317K	–	1962
2020 Q4	$317K	Buy	+4,400	New	+$230K	0.01%	892

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Prelude Capital Management's BEAT Position: Q1 2021 in Review

Prelude Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 2,988 shares — an estimated $215K sold.

Prelude Capital Management first reported a position in BEAT in Q2 2013 and held it in 16 quarters. The position peaked at $2.49M in Q2 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Prelude Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Prelude Capital Management sold 2,988 BioTelemetry, Inc. shares in Q1 2021, an estimated $215K.
Prelude Capital Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 16 quarters.
Prelude Capital Management's BioTelemetry, Inc. position peaked at $2.49M in Q2 2018.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Prelude Capital Management's 13F filing for Q1 2021, filed 17 May 2021.